{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:07:36Z","timestamp":1770822456489,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T00:00:00Z","timestamp":1135209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:p><jats:bold>BACKGROUND:\u2002<\/jats:bold>West Nile virus (WNV) is the etiologic agent of an emerging disease in the Western Hemisphere that can be transmitted to humans by blood transfusion. WNV first appeared in the United States in 1999, in Canada in 2001, and in Mexico in 2002. The aim of this nationwide study was to determine the prevalence of WNV in blood donors in Mexico as a first step in preventing its transfusion\u2010associated transmission.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:\u2002<\/jats:bold>In July and August 2004, a total of 3856 fresh plasma specimens collected from each state's center for blood transfusion in 29 of 31 Mexican states were screened with an investigational WNV assay (Procleix,\u00ae Gen\u2010Probe Inc. and Chiron Corp.), a nucleic acid test based on transcription\u2010mediated amplification (TMA). Reactive specimens were confirmed with a second TMA\u2010based test, the alternative WNV assay (Gen\u2010Probe), and with WNV capture enzyme\u2010linked immunosorbent assays (ELISAs) for detection of immunoglobulin\u2003M (IgM) and IgG antibodies. In addition, 3714 frozen plasma samples collected in 2002 and 2003 were similarly tested.<\/jats:p><jats:p><jats:bold>RESULTS:\u2002<\/jats:bold>One of 3856 fresh samples from an asymptomatic donor from Chihuahua was reactive by both TMA\u2010based tests and IgM ELISA, suggesting a recently acquired infection. The observed percentage of viremic donors blood donors was 0.03\u2003percent. Results from frozen samples were not included in the prevalence calculation and none were TMA\u2010reactive for WNV.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:\u2002<\/jats:bold>WNV is present in the Mexican blood supply and measures should be taken to reduce the risk of transfusion transmission.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2006.00666.x","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T11:02:05Z","timestamp":1135249325000},"page":"111-117","source":"Crossref","is-referenced-by-count":12,"title":["Detection of West Nile virus in the Mexican blood supply"],"prefix":"10.1111","volume":"46","author":[{"given":"Sergio A.","family":"S\u00e1nchez\u2010Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagrario","family":"Romero\u2010Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rodr\u00edguez\u2010Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Infante\u2010Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Villanueva\u2010Vidales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Garc\u00eda\u2010Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana MA.","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime A.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva D.","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldo","family":"Valiente\u2010Banuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Linnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Broulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Harel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael A.","family":"Mar\u00edn y L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,22]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048261"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040682"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.4065\/78.9.1137"},{"key":"e_1_2_7_5_2","first-page":"127A","article-title":"Transfusion\u2010transmitted West Nile virus in Canada 2002","volume":"43","author":"Hume HA","year":"2003","journal-title":"Tranfusion"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106143442401"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21623"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-3-200208060-00009"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030476"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5448.2333"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1111\/j.0041-1132.2004.04227.x","article-title":"Assessing the trade\u2010off between maximum attainable safety and testing capacity for West Nile virus nucleic acid testing of donated blood: analysis of results from 2003 to inform decision\u2010making for 2004","volume":"44","author":"Custer B","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0912.030564"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0907.030166"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0907.030167"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3201\/eid1007.030959","article-title":"Phylogenetic analysis of West Nile virus, Nuevo Leon State, Mexico","volume":"10","author":"Blitvich BJ","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030969"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-7-200404060-00015"},{"key":"e_1_2_7_18_2","volume-title":"Epidemic\/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control [monograph on the Internet].","author":"U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Vector\u2010Borne Infectious Diseases.","year":"2003"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044333"},{"key":"e_1_2_7_20_2","volume-title":"Norma Oficial Mexicana NOM\u2010003\u2010SSA2\u20101993, for the collection and handling of human blood components for therapeutical purposes.","year":"1993"},{"key":"e_1_2_7_21_2","unstructured":"Guidance for industry: assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile virus infection [monograph on the Internet].Rockville (MD):Center for Biologics Evaluation and Research; 2005.Available from:http:\/\/www.fda.gov\/cber\/gdlns\/wnvguid.htm"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03379.x"},{"key":"e_1_2_7_23_2","first-page":"281","article-title":"Update: West Nile virus screening of blood donations and transfusion\u2010associated transmission\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention (CDC).","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_24_2","first-page":"129A","article-title":"Procleix\u00ae WNV assay: a transcription mediated amplification based assay for screening blood donations for West Nile virus RNA","volume":"43","author":"Linnen JM","year":"2003","journal-title":"Transfusion"},{"key":"e_1_2_7_25_2","first-page":"139A","article-title":"Improved specificity of the Procleix\u00ae WNV assay using a modified probe reagent formulation","volume":"44","author":"Linnen JM","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_7_26_2","first-page":"140A","article-title":"Performance assessment of the Procleix WNV assay","volume":"44","author":"Caglioti S","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_7_27_2","volume-title":"Package insert: Procleix West Nile virus assay.","year":"2003"},{"key":"e_1_2_7_28_2","first-page":"138A","article-title":"Gen\u2010Probe alternative WNV assay: a TMA\u2010based confirmatory assay for West Nile virus","volume":"44","author":"Cline J","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2005.04382.x"},{"key":"e_1_2_7_30_2","volume-title":"Package insert: IgM capture ELISA.","year":"2004"},{"key":"e_1_2_7_31_2","volume-title":"Package insert: IgG direct ELISA.","year":"2004"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2005.04315.x"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04401.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22438"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00501.x"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2005.04266.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04130.x"},{"key":"e_1_2_7_39_2","unstructured":"Centers for Disease Control and Prevention (CDC).2004 West Nile Virus viremic activity in the United Statesaccessed athttp:\/\/westnilevirus.nbii.qov. March 2005."},{"key":"e_1_2_7_40_2","first-page":"138A","article-title":"An evaluation of West Nile virus nucleic acid testing on United States blood donors","volume":"44","author":"Gammon RR","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1009.040203"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2002.tb05270.x"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe048146"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2006.00666.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T18:29:14Z","timestamp":1736188154000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2006.00666.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,22]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1537-2995.2006.00666.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2006.00666.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,22]]}}}